UPLOAD Filing
Benitec Biopharma Inc.
Date: Sept. 25, 2025 · CIK: 0001808898 · Accession: 0000000000-25-010472
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-290455
Letter
Re: Benitec Biopharma Inc. Registration Statement on Form S-3 Filed September 22, 2025 File No. 333-290455 Dear Jerel Banks:
September 25, 2025
Jerel Banks Chief Executive Officer Benitec Biopharma Inc. 3940 Trust Way Hayward, CA 94545
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Joshua Gorsky at 202-551-7836 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Louis Rambo, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> September 25, 2025 Jerel Banks Chief Executive Officer Benitec Biopharma Inc. 3940 Trust Way Hayward, CA 94545 Re: Benitec Biopharma Inc. Registration Statement on Form S-3 Filed September 22, 2025 File No. 333-290455 Dear Jerel Banks: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Joshua Gorsky at 202-551-7836 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Louis Rambo, Esq. </TEXT> </DOCUMENT>